Exodus Point Capital Management, LP Tg Therapeutics, Inc. Transaction History
Exodus Point Capital Management, LP
- $14.7 Billion
- Q2 2024
A detailed history of Exodus Point Capital Management, LP transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 1,101,298 shares of TGTX stock, worth $26.2 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
1,101,298
Previous 300,000
267.1%
Holding current value
$26.2 Million
Previous $4.57 Million
329.08%
% of portfolio
0.13%
Previous 0.03%
Shares
11 transactions
Others Institutions Holding TGTX
# of Institutions
287Shares Held
91.8MCall Options Held
1.9MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA13.7MShares$326 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$271 Million0.0% of portfolio
-
State Street Corp Boston, MA6.7MShares$160 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.65MShares$86.9 Million6.57% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.24MShares$77.3 Million0.07% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $3.46B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...